Chordia Therapeutics
190A.TPharmaceutical
Filed as Chordia Therapeutics Inc. (2024-07–2026-04)
Major holders (5%+) · 6
| Holder | Stake |
|---|---|
| Nomura Securities Co., Ltd. | 20.05% |
| Takeda Pharmaceutical Company Limited | 16.42% |
| SBI SECURITIES Co., Ltd. | 13.87% |
| Shinsei Capital Partners, Ltd. | 11.06% |
| SBI Investment Co., Ltd. | 6.63% |
| MIYAKE HIROSHI | 5.73% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 8
| - | 4.85% |
| Kyoto University Innovation Capital Co., Ltd. | 4.68% |
| JAFCO Group Co., Ltd. | 4.53% |
| SMBC Venture Capital Co., Ltd | 4.51% |
| UTokyo Innovation Platform Co., Ltd. | 3.77% |
| Nomura SPARX Investment, Inc. | 2.61% |
| NOMURA INTERNATIONAL PLC | 0.16% |
| Sumitomo Mitsui DS Asset Management Company, Limited | 0.00% |
Ownership history · 58
| Holder | Ratio | Change |
|---|---|---|
| SBI SECURITIES Co., Ltd.2024-06-21 · amended | 20.29% | +19.90pp |
| SBI SECURITIES Co., Ltd.2024-06-21 · amended | 0.39% | -2.10pp |
| SBI Investment Co., Ltd.2024-06-21 · amended | 6.24% | no change |
| SBI SECURITIES Co., Ltd.2024-06-21 · amended | 2.49% | new |
| SBI Investment Co., Ltd.2024-06-21 · amended | 6.24% | new |
| Sumitomo Mitsui DS Asset Management Company, Limited2024-06-21 | 0.54% | new |
| SMBC Venture Capital Co., Ltd2024-06-21 | 6.06% | new |
| -2024-06-21 | 6.07% | new |
| Shinsei Capital Partners, Ltd.2024-06-21 | 11.06% | new |
| Nomura SPARX Investment, Inc.2024-06-20 | 7.71% | new |
| Kyoto University Innovation Capital Co., Ltd.2024-06-20 · amended | 4.68% | -1.11pp |
| Kyoto University Innovation Capital Co., Ltd.2024-06-20 · amended | 5.79% | -1.06pp |
| Kyoto University Innovation Capital Co., Ltd.2024-06-20 · amended | 6.85% | -1.01pp |
| Kyoto University Innovation Capital Co., Ltd.2024-06-20 · amended | 7.86% | -1.02pp |
| Kyoto University Innovation Capital Co., Ltd.2024-06-20 · amended | 8.88% | -1.04pp |
| Kyoto University Innovation Capital Co., Ltd.2024-06-20 · amended | 9.92% | -1.03pp |
| Kyoto University Innovation Capital Co., Ltd.2024-06-20 · amended | 10.95% | new |
| Takeda Pharmaceutical Company Limited2024-06-20 | 16.42% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.